DeviceTalks Podcast Network - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

DeviceTalks Podcast Network — Technology
DeviceTalks Podcast Network

The DeviceTalks Podcast Network is the ultimate destination for all things #MedTech. By subscribing to this single feed, you’ll gain access to every podcast in our diverse and growing portfolio—more than a dozen unique shows featuring senior leaders, groundbreaking technology insights, and in-depth discussions on the most important topics in the medical device industry.

Each episode dives deep into critical areas like business strategy, market trends, surgical robotics, orthopedics, structural heart, neurology, and beyond. You’ll hear from leading voices at top companies—ranging from major OEMs to innovative startups—sharing their solutions, stories, and strategies for tackling the industry’s biggest challenges.

Our Lineup of Shows Includes:
• DeviceTalks Weekly
• AbbottTalks
• Boston Scientific Talks
• DeviceTalks AI
• IntuitiveTalks
• MedtechWOMEN Talks
• MedtronicTalks
• Neuro Innovation Talks: J&J MedTech Neurovascular
• Structural Heart Talks: Edwards Lifesciences
• Ortho Innovation Talks: Enovis & Zimmer Biomet
• StrykerTalks

Why Subscribe?
Subscribing here means you’ll never miss an update from any of our shows. Whether you want a broad overview of the entire industry or prefer to tune into a specific series, this single feed has you covered.

If you discover a favorite topic, you can always subscribe to that individual show’s feed for a more tailored experience.

Meet Your Hosts:
• Tom Salemi, Editorial Director, DeviceTalks
• Kayleen Brown, Managing Editor, DeviceTalks

#DeviceTalks, Where Device Makers Connect.

Copyright: © All rights reserved

Latest Episodes:

Stryker CEO Kevin Lobo shares successful strategies for managing multiple crises (aka life in 2020) Dec 11, 2020

Show notes

The past year of pandemic, social unrest and a divisive election - provided a crash course in crisis management for CEOs. In this week’s DeviceTalks Weekly Podcast, Kevin Lobo, the CEO of Stryker, explains how he led his company through this difficult year. His recipe for success is long, but it includes priorities, communication and listening. Lobo also is serving his final year as chairman of AdvaMed. He shares how that experience gave him an even better appreciation of the medtech industry, which he says got treated unfairly at times but still came through with high grades. Joining us for the first time as a co-host is Nancy Crotti, managing editor of Medical Design and Outsourcing. She’ll talk about the upcoming leadership issue. Meanwhile, Sean Whooley, assistant editor of MassDevice, will share the five big news items of the week aka #NewmarkersNewsmakers. This week’s news comes from Quest, Pfizer, Boston Scientific and Medtronic. And we'll learn which co-host had a steak cooked for them by a future president of the United States. Subscribe today on all your podcast players!

Medtronic CEO Martha explains the why of competing, the reorg, and the importance of institutions Dec 03, 2020

Show notes

In this episode of the DeviceTalks Weekly Podcast, Medtronic CEO Geoff Martha brings us on the inside of Medtronic’s ongoing reorganization. Martha explains how the new company will be structured to work with outside vendors. (Hint: more autonomy, not total autonomy.) He also explains why the company’s push to instill more competitive juice is aligned with its overarching mission of innovation. Martha also discussed his long path to medtech and Medtronic. How he first met Omar Ishrak and why institutions like Medtronic and other medtech companies need to step up on a social scale. This week, Dave Franchino, president of Delve, explains how the company is adapting innovation to fit the pandemic. (And suggests if you’re not finding opportunities to innovate, you’re simply not looking hard enough.) But there is no DeviceTalks party without Chris Newmarker, executive editor of MassDevice, who shares this episode’s Newmarker Newsmakers. Companies covered include Medtronic, Vectorious Medical Technologies, GE Healthcare, Stryker and Butterfly Network. Subscribe today you major podcast platforms!

Enjoy a feast of insights from Spencer Stiles(Stryker) Art Collins(Explorer) and Mark Leahey (MDMA) Nov 21, 2020

Show notes

DeviceTalks Weekly listeners will need some gravy to digest this Thanksgiving feast-sized podcast featuring news and insights from three stellar guests in addition to two new installments of #2minutedetalks chapters from Delve Inc. and Explorer Surgical. This week we visit with… Mark Leahey, president of the Medical Device Manufacturers Association, who explains where medtech might fits in this evolving political climate. Spencer Stiles, group president of orthopaedic and spine at Stryker, who shares details on the Wright acquisition and the secret to the success of placing MAKO surgical robots in hospitals Art Collins, senior advisor to Explorer Surgical. The former Chairman and CEO discusses leadership, Medtronic and the future for startups like Explorer. Also co-host Chris Newmarker, executive editor of MassDevice, shares his selections for this week’s #newmarkersnewsmakers which includes news from BD, Boston Scientific and Johnson & Johnson.

Vizient, Truist on how COVID-19 has changed healthcare’s appetite for buying medical devices Nov 13, 2020

Show notes

This week’s DeviceTalks Weekly Podcast examines medtech’s readiness for the next COVID-19 surge. Hospitals are ready, but their appetite for expensive medical devices has changed, forcing medtech companies to change how they sell or lose out entirely. Justin Cassidy and Henry Soch of Vizient reveal why hospital executives are forced to divert funds away from new devices. They also explain how the power structure in capital purchases is shifting away from technology committees, creating a new challenge for medtech sales teams. Kaila Krum, managing director of Truist Securities, explains how companies like Stryker, Zimmer Biomet and Globus are successfully putting units in hospitals. She confirms medtech companies are being forced to evolve the way they work with hospitals. In the 2-minute-DeTalks, product development leader, podcast and president of Delve Dave Franchino joins us in a 2minute-detalks to explain how the company helps clients find the best solution to vexing problem. (Delve.com.) Explorer Surgical CEO Jennifer Fried makes the case for how her innovative start-ups tech company’s will not only connect surgeons with remote sales reps but also giving a broader view of how successful teams function. Chris Newmarker, executive editor of MassDevice, reveals his #NewmarkersNewsmakers highlighting contributions by Abbott, Stryker, Joe Biden, and EU-MDR.

Where will Intuitive find future growth? Abbott’s Moat on how population boom will boost demand Nov 07, 2020

Show notes

In this episode of the DeviceTalks Weekly Podcast, we’ll talk with Intuitive Surgical's Julian Nikolchev, senior vice president, corporate development and strategy and Oliver Keown, MD, director of Intuitive Ventures, about the new $100 million venture fund. How will the capital be invested? Where does Intuitive see the opportunity, and how does the program fit into the robotic surgical company’s broader mandate to expand the profile of its product offerings? In our opening keynote, Neal Moat, MD, chief medical officer of Abbott’s structural heart business, talks about the success of the MitraClip and the impact COVID-19 is having on patients and Abbott personnel. Chris Newmarker, executive editor of MassDevice, will roll out his Newmarker’s Newsmakers including news about Abbott, Masimo and Stryker. Sean Whooley, assistant editor, will also give an earning wrap on the show highlighting interesting reports from Inspire Medical, Hologic, Stryker and Coloplast. DeviceTalks listeners are also invited to nominate their own Newmarker's Newsmakers of 2020. Use this online ballot to make your suggestions. We'll send out a ballot of the finalists later this month. Go to https://www.surveymonkey.com/r/MWDPVKD to vote! Subscribe today to receive future podcasts!

Hear from Execs Katie Szyman, Naomi Murray, Start-Up CEO Patty Post & Evercore’s Vijay Kumar Oct 31, 2020

Show notes

In this week’s episode of DeviceTalks Weekly the editorial team from MassDevice reviews the Medical Design & Outsourcing’s Women in Medtech issue bringing you insights through interviews with Katie Syzman, corporate VP and the GM of critical care at Edwards Lifesciences, Naomi Murray, Stryker’s director of advanced operations, and Patty Post, CEO of Startup Checkable Medical. Szyman will share Edwards’ view of artificial intelligence. Murray will share her future vision on additive manufacturing while Post will reveal the lessons learned in her first post as startup CEO of a diagnostic company. In our closing keynote conversation, Vijay Kumar, managing director at Evercore ISI, will explain why Exact Science’s acquisition of liquid biopsy company wasn’t exactly a surprise (though the $2 billion pricetag might have been.) He also assesses Boston Scientific’s COVID-19 comeback. What does the rise in cases mean for the company and the rest of medtech? Chris Newmarker, executive editor of life sciences, delivers this week’s Newmarker’s Newsmakers which highlights reports on Abbott, Baxter, Intuitive Surgical and Siemens. Senior Editor Danielle Kirsh also is on hand to talk through MassDevice Big 100 report. Assistant editor Sean Whooley also joins the conversation.

Philips' Imaged Guided leader Landon shares global giant's plans for minimally invasive devices Oct 23, 2020

Show notes

In this week’s DeviceTalks Weekly podcast, we visit with Chris Landon, senior vice president and business leader of image guided therapy devices at Philips about that company’s plans to build a medtech powerhouse. In this conversation we’ll learn -Why Landon left Medtronic -Where Philips fits into medtech’s future -How Philips hopes to expand -Will Philips invest directly in start-ups? -How did Covid-19 impact Philips? We’ll also get Landon’s stance on pumpkin sausages. Disgusting or delicious? We also welcome back Chris Newmarker, executive editor of Mass Device, who delivers his Newmarker's Newsmakers including news from GE Healthcare, Merit Medical, Pharma, Eurofins (Paris:ERF.PA) and DxTerity Diagnostics and the FDA Subscribe today on your podcast apps!

Who will win medtech’s own Supreme Court fight; and can the many mini Medtronics plan work? Oct 16, 2020

Show notes

In this week’s DeviceTalks Weekly podcast, we’ll first delve into Medtech’s own brewing Supreme Court battle. In our opening keynote address sponsored by Medical Design and Outsourcing, J. Michael Jakes, a partner at Finnegan, will tell us why the industry should be watching when the Supremes review the latest patent battle between Arthrex and Smith & Nephew. We’ll also talk about Medtronic’s Analyst Meeting where CEO Geoff Martha and the team rolled out its decentralization plan that calls for the creation of 20 semi-independent business units. Kaila Krum, managing director at Truist Securities, returns to break down the highlight of the meetings including pipelines and partnership with The Foundry, Amazon and others. Sean Whooley, assistant editor at Mass Device, pinch hosts for the vacationing Chris Newmarker and delivered with a rock solid #newmarkersnewsmakers that includes news from Abbott, Arthrex, Smith & Nephew, GE, and, of course, Medtronic.

Smith & Nephew's Ortho President Kiil, Rhaeos CEO Somera's Big Win, and Medtronic's Legacy Oct 09, 2020

Show notes

In this week’s DeviceTalks Weekly Podcast, our opening and closing keynote interviews focus on executives at companies from very different stages. MANUFACTURING AND SOURCING: Skip Kiil took the helm of Smith + Nephew’s global orthopedics business to transform the business. The company’s recent acquisition of Integra’s extremities will further that mission. In our closing keynote conversation, the president of orthopedics updates us on the new technologies and tools that Smith + Nephew is rolling out to help orthopedic patients. Kiil will hit upon Smith + Nephew’s: • CORI Robotics surgical tools • Real Intelligence platform • Interest in Ambulatory Surgery Centers • Balance of OUS vs. US • Future plans for extremities INNOVATION AND FINANCE: Start-up Rhaeos took home this year’s Grand Prize from the Medtech Innovator Global Competition at the Virtual Medtech Conference. In our 0pening keynote, CEO Anna Lisa Somera tells us why she went “all in” on developing a hydrocephalus wearable device that can help this suffering patient population. Somera will discuss • Winning the Global Competition • The power of Rhaeous’ wearable technology • Medtech’s ability to help long suffering patients • The start-up’s fundraising plans. Co-hosts Tom Salemi and Chris Newmarker will also review this week’s biggest stories on MassDevice including former Medtronic CEO Omar Ishrak’s legacy, current Medtronic CEO Geoff Martha’s optimism, and Avail Medsystem’s $100 million plans to grow procedural telemedicine.

Avail Medsystems, AliveCor help surgeons, patients, and sales reps battle COVID through connectivity Oct 02, 2020

Show notes

In a double dose of New Tools and Technology interviews, co-host Tom Salemi talks with two companies using connective technology to build out innovative service businesses.  Medtech veteran Daniel Hawkins, CEO of Avail Medsystems, creator of a procedural telemedicine system that can open up the operating room for sales reps and surgical experts. Hawkins explains how Avail will provide the equipment to hospitals for free while creating new channels for medical device companies to advise surgeons in the operating room. You can learn more about Avail’s approach on our upcoming DeviceTalks Tuesday episode on Oct. 6. https://www.devicetalks.com/devicetalks-tuesdays-agenda/  In our opening interview, Ira Bahr, COO of AliveCor, explains how the company’s AI-enabled, consumer EKG device, KardiaMobile 6L, is connecting heart patient with their physicians. The company is selling the device for patient monitoring both in home and clinical trial settings. How will tech like this open the the clinical trial market. Also, learn how AliveCor is shifting into more of a service company. Meanwhile, co-cost Chris Newmarker, executive editor of life sciences at MassDevice, is off the the races with his #NewmarkersNewsmakers which includes BD, Boston Scientific, Coloplast, Medtronic and Smith+Nephew.

Related Podcasts